Basement Membrane Localized Tumor Cells Are Protected from HER2-Targeted Therapy In Vivo.

被引:0
|
作者
Zoeller, J. J. [1 ]
Bronson, R. T. [1 ]
Gilmer, T. M. [1 ]
Selfors, L. M. [1 ]
Lu, Y. [1 ]
Mills, G. B. [1 ]
Brugge, J. S. [1 ]
机构
[1] Harvard Univ, Sch Med, Boston, MA USA
关键词
D O I
10.1158/0008-5472.SABCS11-S5-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
S5-3
引用
收藏
页数:1
相关论文
共 50 条
  • [21] HER2-targeted therapy in colorectal cancer: a comprehensive review
    Benli, Yeliz
    Arikan, Helin
    Akbulut-caliskan, Ozge
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025,
  • [22] Late cardiotoxicity related to HER2-targeted cancer therapy
    Isabelle Senechal
    Maria Sol Andres
    Jieli Tong
    Ylenia Perone
    Sivatharshini Ramalingam
    Muhummad Sohaib Nazir
    Stuart D Rosen
    Nicholas Turner
    Alistair Ring
    Alexander R Lyon
    Cardio-Oncology, 10
  • [23] The gut microbiota contributes to the effectiveness of HER2-targeted therapy
    Di Modica, Martina
    Regondi, Viola
    Gargari, Giorgio
    Bonizzi, Arianna
    Arioli, Stefania
    Belmonte, Beatrice
    Tripodo, Claudio
    Guglielmetti, Simone
    Corsi, Fabio
    Triulzi, Tiziana
    Tagliabue, Elda
    CANCER RESEARCH, 2019, 79 (13)
  • [24] Recent advances in HER2-targeted delivery for cancer therapy
    Dhritlahre, Rakesh Kumar
    Saneja, Ankit
    DRUG DISCOVERY TODAY, 2021, 26 (05) : 1319 - 1329
  • [25] Late cardiotoxicity related to HER2-targeted cancer therapy
    Senechal, Isabelle
    Andres, Maria Sol
    Tong, Jieli
    Perone, Ylenia
    Ramalingam, Sivatharshini
    Nazir, Muhummad Sohaib
    Rosen, Stuart D.
    Turner, Nicholas
    Ring, Alistair
    Lyon, Alexander R.
    CARDIO-ONCOLOGY, 2024, 10 (01)
  • [26] The tumor immune microenvironment remodeling and response to HER2-targeted therapy in HER2-positive advanced gastric cancer
    Jiang, Lei
    Zhao, Xingwang
    Li, Yilin
    Hu, Yajie
    Sun, Yu
    Liu, Shengde
    Zhang, Zizhen
    Li, Yanyan
    Feng, Xujiao
    Yuan, Jiajia
    Li, Jian
    Zhang, Xiaotian
    Chen, Yang
    Shen, Lin
    IUBMB LIFE, 2024, 76 (07) : 420 - 436
  • [27] MNX1 promotes tumor sensitivity to HER2-targeted therapy in HER2-positive breast cancer
    Chi, Wei-Ru
    Xiu, Bingqiu
    Xiong, Min
    Li, Pei
    Zhang, Qi
    Li, Lun
    Hou, Jianjing
    Zhou, Xujie
    Sang, Yuting
    Chen, Ming
    Zhang, Liyi
    Xue, Jingyan
    Chi, Yayun
    Wu, Jiong
    CANCER RESEARCH, 2023, 83 (05)
  • [28] HER3 MUTATIONS AFFECT TUMOR RESPONSE TO HER2-TARGETED THERAPIES
    不详
    CANCER DISCOVERY, 2021, 11 (09) : 2122 - 2122
  • [29] Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: A sub-study from the NeoALTTO phase III trial
    Azim, Hatem A.
    Rothe, Francoise
    Monica Aura, Claudia
    Bavington, Malcolm
    Maetens, Marion
    Rouas, Ghizlaine
    Gebhart, Geraldine
    Gamez, Cristina
    Eidtmann, Holger
    Baselga, Jose
    Piccart-Gebhart, Martine
    Ellis, Catherine
    Vuylsteke, Peter
    Cure, Herve
    Domont, Julien
    Ferro, Antonella
    Carlos Toral-Pena, Juan
    de Azambuja, Evandro
    Sotiriou, Christos
    Di Cosimo, Serena
    Ignatiadis, Michail
    BREAST, 2013, 22 (06): : 1060 - 1065
  • [30] HER2-Targeted Therapy-From Pathophysiology to Clinical Manifestation: A Narrative Review
    Slavcheva, Svetoslava Elefterova
    Angelov, Atanas
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2023, 10 (12)